Effect of phosphodiesterase-4 inhibitor on the inflammation, oxidative damage and apoptosis in a saline lavage-induced model of acute lung injury Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018
Rho-kinase inhibitor ameliorates bleomycin-induced chronic lung injury in neonatal rats Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care Year: 2011
Angiotensin II antagonism fails to ameliorate bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2005; 25: 708-714 Year: 2005
Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury Source: Eur Respir J 2008; 31: 633-644 Year: 2008
Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury Source: Eur Respir J 2003; 22: 20-27 Year: 2003
Effects of matrix metalloproteinase inhibitor on ventilator-induced lung injury in rats Source: Eur Respir J 2002; 20: Suppl. 38, 486s Year: 2002
Angiotensin-converting enzyme 2 expression is not induced by the renin–angiotensin system in the lung Source: ERJ Open Res, 6 (4) 00402-2020; 10.1183/23120541.00402-2020 Year: 2020
Angiotensin II receptor blockers, ACE inhibitors, lung function and percent emphysema; the MESA lung study Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012
The effects of tpl2 inhibition in Ventilator-induced lung injury Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017
Role of poly(ADP-ribose) polymerase-1 and its inhibitor in ventilator-induced lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 559s Year: 2004
The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020
sGC activator BAY 412272 attenuates ischemia/reperfusion injury of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 822s Year: 2006
PD98059 attenuates the development of bleomycin-induced lung injury and fibrosis Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010
Abrogation of bleomycin induced inflammation and lung fibrosis by angiotensin AT1 receptor antagonist. Relevance of PGE-2 modulation Source: Eur Respir J 2005; 26: Suppl. 49, 82s Year: 2005
Effects of phosphodiesterase inhibitors on the lung functions in a saline lavage-induced model of acute lung injury Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents Year: 2017
The role of apoptosis in pulmonary fibrosis Source: Eur Respir Rev 2008; 17: 138-144 Year: 2008
Gabexate mesilate attenuates ischemia-reperfusion injury of lung grafts via the inhibition of neutrophil activation Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005
Effects of angiotensin-converting enzyme inhibitor on peripheral skeletal muscle dysfunction in emphysematous rats Source: Annual Congress 2008 - Physiological response to exercise performance Year: 2008
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib, naphthalene-induced acute pneumonitis in mice Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015
The role of pendrin in acute lung injury caused by ventilator-induced lung injury Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020